<DOC>
	<DOCNO>NCT01109381</DOCNO>
	<brief_summary>At present , triple therapy recommend various guideline treatment Helicobacter pylorus ( H.pylori ) infection . Recent study show increase resistance H.pylori commonly use antibiotic used triple therapy . This study explore non-antibiotic treatment regime H.pylori use lauric acid primary anti-microbial agent . The study hypothesis Lauric acid work synergistically omeprazole follow administration mucolytic agent kill H.pylori topically stomach .</brief_summary>
	<brief_title>Safety Efficacy Study Non-antibiotic Treatment Eradication Helicobacter Pylori</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Helicobacter Infections</mesh_term>
	<mesh_term>Omeprazole</mesh_term>
	<criteria>Informed Consent prior study procedure Age least 21 year 70 year If female childbearing potential sexually active , agree use acceptable method birth control throughout study . Acceptable method birth control : hormonal contraceptive ( birth control pill ) , intrauterine device ( IUD ) , diaphragm spermicide , condom , vasectomy . Additional Inclusion Criteria Initial Phase Healthy volunteer gastrointestinal symptom require medical treatment consider investigator clinically minor irrelevant conduct study . Positive laboratory serology H.pylori Positive Urea Breath Test H.pylori Willing undergo two gastroscopy procedure Additional Inclusion Criteria Secondary Phase Either healthy volunteer patient attend gastroenterology outpatient clinic gastrointestinal symptom consider investigator clinically minor irrelevant conduct study . Positive diagnosis current H.pylori infection , diagnose positive Urea Breath Test least one following : 1 ) Positive laboratory serology H.pylori , 2 ) know positive Campylobacterlike organism ( CLO ) test H.pylori culture gastroscopy perform 1 year prior Screening . Pregnant breast feeding . Clinically significant gastric disease , opinion investigator . Significant disease disorder general medical examination , opinion investigator ( general , respiratory , cardiovascular , renal , hepatic , neurological , bleeding tendency etc ) . Regular intermittent use antibiotic , nonsteroidal antiinflammatory drug ( NSAIDs ) , anticoagulant antiplatelet medication expect trial period . Cessation proton pump inhibitor H2blocker therapy 2 week prior Urea Breath Test likely best interest participant . Laboratory value blood test outside laboratory normal range consider clinically relevant investigator : following screen Haemoglobin ( Hb ) , bilirubin , aspartate transaminase ( AST ) , alanine transaminase ( ALT ) , serum albumin , Alkaline Phosphatase , Urea , sodium ( Na ) , potassium ( K ) , creatinine ( CRE ) . Any contraindication treatment omeprazole , Nacetyl cysteine ( NAC ) , sodium bicarbonate . Any evidence organic psychiatric disorder likely result poor compliance opinion investigator . Previous participation trial time , participation clinical trial within previous 3 month .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>bacterial infection</keyword>
	<keyword>anti-infective agent</keyword>
	<keyword>gastrointestinal agent</keyword>
	<keyword>antibacterial agent</keyword>
	<keyword>omeprazole</keyword>
	<keyword>lauric acid</keyword>
	<keyword>n-acetylcysteine</keyword>
	<keyword>helicobacter infection</keyword>
	<keyword>helicobacter pylorus</keyword>
	<keyword>non-antibiotic treatment</keyword>
</DOC>